 |
What Is Happening Tomorrow podcast (Hebrew, from 19:20 minutes)
GLZ, October 20, 2022
|
 |
Israeli Breakthrough Company Seeks To Use Cells To Improve Quality Of Life
Jerusalem Post, September 2, 2022
|
 |
CEO Yaky Yanay at 30 Minutes Or Less podcast (Hebrew)
30 Minutes Or Less, August 16, 2022
|
 |
Pioneering Israeli Biotech: Pluri
B’nai B’rith Int’l Podcast, August 5, 2022
|
 |
Vegetarian Meat (Hebrew)
ידיעות אחרונות, June 14, 2022
|
 |
Joining forces to advance the food industry (Hebrew)
Technion Magazine, Summer 2022
|
 |
Can you grow sustainable, delicious meat in a lab?
The David Suissa Podcast, May 13, 2022
|
 |
Israeli companies at NASDAQ want to bring lab-grown meat to the masses
Jewish Telegraphic Agency, March 30, 2022
|
 |
“Cell-Based, Innovative Products for a Better Future”
The Jerusalem Post, March 10, 2022
|
 |
Biotech Serves Breakthrough Therapies, With A Side Of Cultured Meat
JewishPress.com, February 17, 2022
|
 |
Israel’s Foodtech Convention (Hebrew)
Channel 12 Keshet, February 10, 2022
|
 |
Israel’s biggest food maker enters JV to put ‘affordable cultured food on the table’
FoodNavigator.com, January 18, 2022
|
|
Israel’s Tnuva and Pluristem to Develop Cultured Cell-Based Meat
The Jerusalem Post, January 10, 2022 |
 |
Tnuva and Pluristem Set Up Cultured Meat JV
Globes, January 10, 2022 |
 |
A New Standard of International Conferences (Hebrew)
TheMarker, December 7, 2021
|
 |
Key Considerations and Risk Management Best Practice for Placenta-Derived Cell Therapy Raw Materials
Cell & Gene Therapy Insights, October 22, 2021
|
 |
The 22 most interesting Israel-UAE agreements of the year
Israel21C, September 12, 2021
|
 |
Israel: The ‘Start-Up Nation’ is now the ‘Biotech Nation’ – opinion
The Jerusalem Post, August 4, 2021
|
 |
Analytical Methods for Cell Therapies: Method Development and Validation Challenges
BioProcess International, June 18, 2021
|
 |
Pluristem CEO touts a new generation of medical treatments
Khaleejtimes, June 10, 2021
|
 |
Pluristem Speaks at The Jerusalem Post’s Global Investment Forum 2021 in Dubai
June 9, 2021
|
 |
Yaky Yanay, CEO de Pluristem : «Nous lançons des traitements médicaux de nouvelle génération»
L’Observateur du Maroc et de l’Afrique, June 4, 2021
|
|
Yaky Yanay : « La biotechnologie pourra sauver le monde des virus à venir
L’Observateur du Maroc et de l’Afrique, June 3, 2021
|
|
Advancing Tech, Medicine, and Togetherness at the Global Investment Forum
The Jerusalem Post, June 1, 2021
|
|
Global Investment Forum to turn UAE-Israel collaborations into reality
The Jerusalem Post, May 26, 2021
|
 |
Israeli biotech leader calls for Arab-Jewish coexistence
Israel 21C, May 17, 2021
|
 |
CEO Yaky Yanay at Geekonomy podcast (Hebrew)
May 5,2021
|
|
Pluristem’s placenta cells induce body to create new blood cells – study
The Jerusalem Post, May 02, 2021
|
 |
Genesis Prize and Start-up Nation Central announce winners of the competition in honor of Natan Sharansky
The Genesis Prize, December 24, 2020
|
|
Interview with Dr. Racheli Ofir, VP Research & IP and Ein Mahel High School student about the educational biological experiment with The Ramon Foundation (Hebrew)
Channel 12 Morning Show, December 04, 2020
|
 |
Industrializing allogeneic cell therapy bioprocessing: devising streamlined solutions to complex challenges
Cell & Gene Therapy Insights, November 23, 2020
|
 |
Pluristem is ranked the 26th Best Hi-Tech company to work for in Israel in 2020 (Hebrew)
CALALIST, October 26, 2020
|
 |
Coliseum Medical Centers in Macon testing potential COVID-19 treatment
13WMAZ, October 19, 2020
|
 |
An Israeli company and a company from Abu Dhabi are developing an innovative treatment for Corona
KAN11, October 19, 2020
|
 |
Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel
The New York Times, October 07, 2020
|
 |
Israeli and Emirati companies join forces to develop COVID-19 treatment
The Jerusalem Post, October 02, 2020
|
|
Abu Dhabi Stem Cells Center and Pluristem Unveil Joint Projects at Malta Conferences Foundation Online Event
The New York Times, October 01, 2020
|
|
Pluristem Launches FDA-Cleared COVID-19 Expanded Access Program, Enabling Patient Treatment Outside of Clinical Trial
The New York Times, August 27, 2020
|
 |
Israeli Pluristem will Cooperate with Abu Dhabi Medical Center (Hebrew)
ידיעות אחרונות, August 27, 2020
|
 |
The first medical cooperation agreement between two companies – an Israeli and an Emirati (Arabic)
Bokra, August 20, 2020
|
 |
Stem cell centres in UAE, Israel sign agreement
Khaleej Times, August 18, 2020
|
 |
Cooperation between Israel and Abu Dhabi (Hebrew)
Israeli Channel 12, August 17, 2020
|
 |
Israeli-based Pluristem and Abu Dhabi Stem Cells Center sign deal to collaborate in development of cell therapies
Calcalist, August 17, 2020
|
|
Will the cure come from the placenta? Pluristem will begin a Phase II study in Germany for COVID-19 patients (Hebrew)
Calcalist, August 10, 2020
|
 |
Some potentially positive COVID news?
The Times of Israel, August 07, 2020
|
 |
Broadway Set Designer Survives Covid-19 After 46 Days On Ventilator
The Tamron Hall Show, August 03, 2020
|
 |
Supported by the European Investment Bank: The Israeli company trying to find treatment for COVID-19 (Hebrew)
Walla, July 26, 2020
|
 |
Edward Pierce’s Miracle: How a Broadway Set Designer Beat Covid and Made Medical History
THEATERMANIA, June 25, 2020
|
 |
Has Pluristem Therapeutics (PSTI) Outpaced Other Medical Stocks This Year?
Yahoo Finance, June 01, 2020
|
 |
Cell therapy’s role in defeating Covid-19
Cell & Gene Therapy Insights, May 27, 2020
|
|
Israel’s Pluristem: 75% of treated COVID-19 patients off ventilators
The Jerusalem Post, May 16, 2020
|
 |
Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S.
Israeli Life Sciences, May 14, 2020
|
|
Israel’s Pluristem FDA approved for study in treatment of severe COVID-19
The Jerusalem Post, May 08, 2020
|
 |
Regenerating the body’s healing mechanisms for COVID-19 patients
Science Business, May 07, 2020
|
 |
Roundup: Israeli hi-tech firms focus on seeking solutions to COVID-19 challenges
Xinhua News Agency – China , May 06, 2020
|
|
Will placenta cells beat the corona? The Israeli treatment that intrigues the world (Hebrew)
Israeli Channel 12, May 2, 2020
For English subtitles click here
|
 |
Fighting the Corona: First Agreement Between the EU and Israel (Hebrew)
Maariv, May 1, 2020
|
 |
Lean, mean, cold-chain machine (page 60)
World Pharmaceutical Frontiers, May, 2020
|
|
European Investment Bank, Israel Innovation Authority Collaborate on Medical Investments
Calcalist, April 30, 2020
|
 |
€50 loan from European Investment Bank to Israeli company Pluristem
Israel National News Channel 7, April 30, 2020
|
 |
Stem cells from a baby’s placenta may save life of coronavirus victim in NJ
New York Post, April 13, 2020
|
|
Israeli COVID-19 treatment shows 100% survival rate – preliminary data
The Jerusalem Post, April 12, 2020
|
 |
Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19
BioSpace, April 09, 2020
|
|
We are on it- main Israeli developments to deal with Covid-19 (Hebrew)
ידיעות אחרונות, April 03, 2020
|
|
Israeli company uses placenta cells to treat critical COVID-19 patients
The Jerusalem Post, March 30, 2020
|
 |
Three Corona patients in Israel have been treated with Israeli placenta-based medicine (Hebrew)
The Marker, March 30, 2020
|
 |
Israeli technological developments attempting to cope with the Covid_19 Coronavirus (Hebrew)
Israeli Channel 13, March 24, 2020
|
 |
Israel to weigh “compassionate use” of Pluristem therapy for COVID-19
Reuters, March 17, 2020
|
|
Israeli cell therapy could treat respiratory effects caused by coronavirus
The Jerusalem Post, March 15, 2020
|
| |
Israeli cell therapy demand could be worth $2 billion by 2023
The Jerusalem Post, February 9, 2020
|
 |
How Is Biotechnology Used In Space Exploration Missions?
Scientist Live, December 17, 2019
|
 |
Pluristem Completes 75% Enrollment in its Pivotal Phase III CLI Clinical Study
The Wall Street Journal, December 17, 2019
|
 |
Taking It All The Way To Phase 3 Clinical Trials
Life Science Leader, November 1, 2019
|
 |
Holy Name clinical trial tests the healing power of stem cells
NJTV News, October 18, 2019
|
 |
Positive results for radiation prophylaxis
DrugDiscoveryNews, October, 2019
|
 |
Pluristem Therapeutics Recaps Key Opinion Leader Call Reviewing Hematological Programs
Bloomberg, September 16, 2019
|
 |
Pluristem gets positive results from radiation treatment trials
Reuters, July 31, 2019
|
 |
Regenerative Medicine Companies Pursue Unique Regulatory Pathways
Applied Clinical Trials, July 09, 2019
|
|
Israeli medicine company aims to manufacture cannabinoid-producing cells
The Jerusalem Post, May 8, 2019
|
 |
NASA looks to Israeli biotech firm to solve long duration spaceflight
Politico, May 03, 2019
|
 |
To Reach Mars, We Need Biotechnology
Labiotech.eu, March 27, 2019
|
 |
The rise of regenerative medicine
News Channel 13, March 23, 2019
|
 |
Stem cell therapies for space missions? Pluristem joins forces with NASA to combat space-related ailments
EndPoints News, February 20, 2019
|
 |
Pluristem’s Point-Of-Care Thawing Device To Be Manufactured And Distributed By Chart Industries
Biobanking, December 17, 2018
|
 |
Human placenta stem cells help people recover from hip surgery
New Scientist, October 17, 2018
|
 |
IRMC patient receives historic stem cell surgery
The Indiana Gazette, September 23, 2018
|
 |
Does the Placenta Hold the Answer to One of Our Most Challenging Medical Problems?
Bloomberg, September 10, 2018
|
 |
Thermo Fisher, Pluristem partner to scale up regenerative cell therapy manufacturing
Fierce Bio Tech, July 9, 2018
|
 |
Clinical trial at Holy Name aims to save limbs and lives
NJTV news, June 26, 2018
|
 |
Study shows placenta treatment effective against radiation sickness
The Times of Israel, June 26, 2018
|
 |
US DoD to study PLX-R18 cell therapy to treat mustard gas injuries
Army technology, June 21, 2018
|
|
Israel’s Pluristem sees positive results from leg pain study
Reuters, June 12, 2018
|
|
Pluristem Breakthrough Brings Global Hope for Radiation Treatment
Bloomberg, May 22, 2018
|
|
FDA clears Pluristem radiation treatment for emergency use
Reuters, April 30, 2018
|
 |
Uma vacina contra radiacoes nucleares
Sic noticias, March 24, 2018 (Portuguese)
|
|
Smart cells that heal
The Jerusalem Post, February 14, 2018
|
 |
North Korea nuclear fears boost demand for survivalist gear, services
The Washington Times, February 01, 2018
|
|
North Korea threats spur U.S. search for new radiation therapies
Reuters, January 31, 2018
|
|
New hope for cancer patients
The Jerusalem Post, January 12, 2018
|
 |
Stem Cell Manufacturing: It’s All about Scale
GEN news, January 1, 2018
|
 |
FDA clears expanded access programme for Pluristem’s PLX-PAD cell treatment
EPM magazine, January 10, 2018
|
 |
Pluristem Gets Accelerated Approval Pathways in Top 3 Healthcare Markets – U.S., Europe, Japan
Bio Informant, December 7, 2017
|
|
‘It’s time to invest in cell-based treatment for nuclear exposure’
The Jerusalem Post, December 7, 2017
|
 |
Pluristem’s innovative technology, cell therapy products and a potentially answer for radiation exposure
i24News (French), November 19, 2017
|
 |
Trending 2018: Pipeline Disrupters
Pharma Voice, November 2017
|
 |
Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chronic GvHD
The New York Times, November 6, 2017
|
|
Health Ministry approves pioneering placenta-cell therapy for blood disorders
Jerusalem Post, October 29, 2017
|
 |
Die Welt (in German)
October 20, 2017
|
|
Can the organ of life save lives?
Jerusalem Post, October 20, 2017
|
 |
Pluristem Therapeutics (PSTI) Stock: Gaining On Orphan Drug Designation
CNA Finance, October 19, 2017
|
 |
Cell Therapy for Chronic Disease
Drug Descovery & Development, October 18, 2017
|
|
New Published Data Highlights the Potential of Pluristem’s PLX Cells in Improving Cardiac Function in Diabetes
BioSpace, October 16, 2017
|
 |
Pluristem: 3D Macrocarrier Bioreactor Technology Overcomes Limitations of 2D Microcarriers
Drug Development & Delivery, October issue 2017 |
|
U.S. FDA Grants Fast Track Designation to Pluristem’s PLX-PAD for the Treatment of CLI
BioInformant, September 18, 2017
|
 |
Pluristem Strengthens Its Position in Asia, Awarded Two New Patents in Hong Kong for Critical Limb Ischemia and Muscle Regeneration
Market Insider, September 13, 2017
|
 |
Stem cell co Pluristem awarded $8.7m EU grant
Globes, September 6, 2017
|
 |
US military testing radiation exposure drug
CNN, September 5, 2017
|
|
U.S. DOD to Start New Trial with Pluristem’s PLX-R18 Cell Therapy Against ARS
GEN news, August 17, 2017
|
 |
Surviving a Nuclear Attack
Real Clear Defense, August 4, 2017
|
 |
Scientists find ‘cure’ for nuclear radiation exposure
Energy Voice, July 27, 2017
|
 |
Pluristem’S Radiation Antidote Addresses $11 Billion Hematologic Indication In Human Trials
Seeking Alpha, July 23, 2017
|
 |
This new drug could help the U.S. survive a nuclear meltdown
Market Watch, July 18, 2017
|
|
The Israeli company protecting against radiation catastrophe
Jerusalem Post, July 14, 2017
|
|
Pluristem Therapeutics (PSTI) Advances Its Multinational Phase III Critical Limb Ischemia Study
BioSpace, July 10, 2017
|
|
The Health System Care in Israel- A Reference to the OECD report (Hebrew)
Globes. July 3, 2017
|
 |
Critical Limb Ischemia- an unmet need
FYI News, June 2017
|
|
Cell therapy – the next generation of biological therapeutic products
FYI News, June 2017
|
|
Placental cell therapy
FYI News, June 2017
|
|
The Israeli company protecting against radiation catastrophe
Jerusalem Post, May 26, 2017
|
 |
Pocket-size biological solution to radioactive threats
Homeland Security news wire, May 15, 2017
|
|
Homeland Security Today, April 20, 2017
|
 |
Can Pluristem Therapeutics (PSTI) Corner The Acute Radiation Syndrome(ARS) Market?
CNA Finance, April 10, 2017
|
 |
US Tests Potential Israeli Cure for Victims of ‘Nuclear Terrorism’
Defense News, March 30, 2017
|
|
CELL THERAPY – PLX-R18: Cell Therapy for Treatment of Acute Radiation Syndrome & Bone Marrow Failure Diseases
Drug Development, February 28, 2017
|
 |
Regenerative Medicine for Effective, Non-Invasive Treatment of Critical Limb Ischemia
The Bio Connection, February 15, 2017
|
|
Pluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood Transplants
GEN news, December 27, 2016
|
|
Pluristem, Sosei Set Up in Japan to Commercialize Cell Therapy for CLI
GEN news, December 20, 2016
|
|
Phase III Cell Therapy Company Pluristem Gets $8 Million Grant For Pivotal Trial In $12 Billion CLI Market
Seeking Alpha, August 21, 2016
|
 |
Pluristem: Trial of PLX-PAD Cells for Femoral Neck Fracture
Orthopedics this week, August 11, 2016
|
